Site icon Todd K Marsha

One Of World’s Most Famous Drugs Could Unlock Solution For Alzheimer’s

One Of World’s Most Famous Drugs Could Unlock Solution For Alzheimer’s

<p><&excl;-- BEGIN THEIA POST SLIDER --><&sol;p>&NewLine;<p> <br &sol;>&NewLine;<&sol;p>&NewLine;<div style&equals;"position&colon;relative" data-narration-container&equals;"true">&NewLine;<p><span style&equals;"font-weight&colon;400">An erectile dysfunction drug from South Korea could become the first pill approved in the United States to slow Alzheimer’s disease&period;<&sol;span><&sol;p>&NewLine;<p><span style&equals;"font-weight&colon;400">Researchers announced this week that a lower-dose version of the drug — sold as Mvix in South Korea for erectile dysfunction — helped slow mental decline in a yearlong trial of more than 1&comma;500 people with early-stage Alzheimer’s&comma; The Washington Post <&sol;span><a href&equals;"https&colon;&sol;&sol;www&period;washingtonpost&period;com&sol;health&sol;2026&sol;11&sol;17&sol;first-pill-slow-alzheimers-could-come-an-unexpected-place&sol;" target&equals;"&lowbar;blank" rel&equals;"noopener"><span style&equals;"font-weight&colon;400">reported<&sol;span><&sol;a><span style&equals;"font-weight&colon;400">&period; <&sol;span><span style&equals;"font-weight&colon;400">But the experimental treatment&comma; called AR1001&comma;<&sol;span> appeared to work only in those who were not taking other medications for dementia&period;<&sol;p>&NewLine;<p><span style&equals;"font-weight&colon;400">Among the roughly <&sol;span>40&percnt; of participants who weren’t taking other dementia drugs&comma; the pill slowed decline by about 31&percnt; compared with the placebo group&period; The rest of the participants&comma; those who were on other dementia medications&comma; exhibited little to no benefit&period; Across the full trial population&comma; the benefit was not statistically significant&period; <span style&equals;"font-weight&colon;400">Researchers measured decline through assessments that included interviews with the patients and their caregivers about memory&comma; judgment&comma; and their daily lives&period;<&sol;span><&sol;p>&NewLine;<p>AriBio&comma; the South Korean company repurposing the drug&comma; said it plans to discuss with the Food and Drug Administration whether the trial results are sufficient or whether another trial is needed&period;<&sol;p>&NewLine;<p>If the low-dose version of <span style&equals;"font-weight&colon;400">Mvix <&sol;span>were to get approved&comma; it would be the first pill authorized in the country to slow Alzheimer’s&comma; according to Sharon Sha&comma; a neurologist who directs the Stanford Center for Memory Disorders and led the trial&period;<&sol;p>&NewLine;<p>Sha presented the group’s findings at the Clinical Trials on Alzheimer’s Disease conference on Monday&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;To have a disease-modifying drug with relatively minimal side effects that is oral would be huge&comma;” she said&period; &OpenCurlyDoubleQuote;It’s very exciting and promising&period;”<&sol;p>&NewLine;<p>Reported side effects included diarrhea&comma; dizziness&comma; falls and fainting&period;<&sol;p>&NewLine;<p>AriBio has been testing the Viagra-like drug since late 2022 at a daily dose of 30 milligrams — less than a third of the 100-milligram dose used for erectile dysfunction&period;<&sol;p>&NewLine;<p>Richard Oakley&comma; an associate director for research and innovation at Alzheimer’s Society in the United Kingdom&comma; <a href&equals;"https&colon;&sol;&sol;www&period;thetimes&period;com&sol;uk&sol;healthcare&sol;article&sol;alzheimers-drug-viagra-medication-b0l33kdz3" target&equals;"&lowbar;blank" rel&equals;"noopener">said<&sol;a> the results could change the future of Alzheimer’s treatment&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;These topline results are an exciting sign that we could have a totally new treatment for early Alzheimer’s disease that tackles its causes&comma; not just its symptoms&comma;” he said&period; &OpenCurlyDoubleQuote;&lbrack;The drug&rsqb; takes a novel approach&comma; relaxing blood vessels to increase blood flow to the brain&period; And unlike other disease-modifying treatments that have shown benefits in late-stage trials&comma; it is taken as a once-a-day tablet&comma; which could make treatment simpler&period;”<&sol;p>&NewLine;<&sol;div>&NewLine;<p><br &sol;>&NewLine;<br &sol;><a href&equals;"https&colon;&sol;&sol;www&period;dailywire&period;com&sol;news&sol;one-of-worlds-most-famous-drugs-could-unlock-solution-for-alzheimers">Source link <&sol;a><&sol;p>&NewLine;<p><&excl;-- END THEIA POST SLIDER --><&sol;p>&NewLine;

Exit mobile version